3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
4
NIH
3
NETWORK
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
2
Interventions
Cyclophosphamide
42
Docetaxel
33
Paclitaxel
31
Tamoxifen
29
Doxorubicin
29
Trastuzumab
25
Radiotherapy
21
Epirubicin
16
Letrozole
15
Anastrozole
12
exemestane
11
Fluorouracil
11
Capecitabine
10
Bevacizumab
10
palbociclib
9
Immunohistochemistry
9
Fulvestrant
9
Filgrastim
9
Lapatinib
8
Zoledronic Acid
7
Methotrexate
7
Magnetic Resonance Spectroscopy
7
Gene Expression Profiling
7
pertuzumab
6
Triptorelin Pamoate
6
Taxes
6
Surgical Procedures, Operative
6
Microarray Analysis
6
Goserelin
6
Chemotherapy, Adjuvant
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
NETWORK
×
Ovariectomy
×
Breast
×
Clear all
NCT00066690
2026-02-06
SOFT
ETOP IBCSG Partners Foundation
Phase 3
Completed
3,066 enrolled
15 charts
NCT00066807
2016-10-28
PERCHE
ETOP IBCSG Partners Foundation
Phase 3
Terminated
29 enrolled
6 charts